RingelMD, SosaJA, BalochZ, et al.2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer. Thyroid, 2025; 35(8):841–985; doi: 10.1177/10507256251363120.
2.
BauzonJ, ShinJ, PlittG, et al.Validation of molecular profiling to preoperatively predict aggressive pathologic features in differentiated thyroid cancer. Surgery, 2026; 189:109698; doi: 10.1016/j.surg.2025.109698.
3.
Ywata de CarvalhoA, KohlerHF, et al.Predictive factors for recurrence of papillary thyroid carcinoma: Analysis of 4,085 patients. Acta Otorhinolaryngol Ital, 2021; 41(3):236–242; doi: 10.14639/0392-100X-N1412.
4.
GoldingA, BimstonD, NamiranianE, et al.Development and validation of mRNA expression-based classifiers to predict low-risk thyroid tumors. Front Endocrinol (Lausanne), 2025; 16:1600815; doi: 10.3389/fendo.2025.1600815.
